Splash Beverage Group Invests in Avicanna, a Leading Cannabinoid Biopharmaceutical Platform, Advancing Its Transformation Into Cannabinoid HealthcareFORT LAUDERDALE, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) today announced the completion of a CDN$300,000 strategic investment in Avicanna Inc. (TSX: AVCN), a commercial-stage cannabinoid-based biopharmaceutical company focused on clinical research, patient care, and developing pharmaceutical products.
Splash Beverage Group Provides Corporate Update on NYSE Compliance Process and Strategic Transaction InitiativesFORT LAUDERDALE, Fla., June 03, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) ("Splash" or the "Company"), today provided a corporate update regarding its NYSE American compliance process, ongoing strategic transaction initiatives, and certain required disclosures.
Splash Beverage Group Receives NYSE Notice Regarding Shareholders’ Equity Requirement; will execute a plan to Regain ComplianceFORT LAUDERDALE, Fla., May 05, 2026 (GLOBE NEWSWIRE) -- Splash Beverage Group, Inc. (NYSE American: SBEV) (“Splash” or the “Company”), today announced that on April 29, 2026, it received a notice from NYSE Regulation (the “NYSE”) indicating that the Company is not currently in compliance with the NYSE’s continued listing standards related to minimum shareholders’ equity. In accordance with NYSE requirements, the Company is required to submit a plan by May 29, 2026, outlining the actions it has taken or will take to regain compliance. If the plan is accepted, the Company may be granted a cure period extending through January 29, 2027 to restore compliance with the continued listing standards.
